Comparative therapeutic use of Risedronate and Calcarea phosphorica - Allopathy versus homeopathy - In bone repair in castrated rats

Brazilian Oral Research

Volumn 20, Issue 3, 2006, Pages 196-201

  Werkman, Cristina ^a   Senra, Giselle Segnini ^a   da Rocha, Rosilene Fernandes ^a   Brandão, Adriana Aigotti Haberbeck ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Allopathy; Calcarea phosphorica; Fracture healing; Homeopathy

Indexed keywords

EID: 33750352951     PISSN: 18068324     EISSN: 18073107     Source Type: Journal    
DOI: 10.1590/s1806-83242006000300003     Document Type: Article

References (19)

1. Bae DC, Stein BS. The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate. J Urol 2004;172(6Pt 1):2137-44.
2. Blake GM, Fogelman I. Bone densitometry, steroids and osteoporosis. Curr Opin Nephrol Hypertens 2002; 11(6):641-7.
3. Boonen S, Haentjens P, Vandenput L, Vanderschueren D. Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes. J Intern Med 2004;255(1):1-12.
4. Calero JA, Curiel MD, Moro MJ, Carrascal MT, Santana JS, Avial MR. Speed of sound, bone mineral density and bone strength in oophorectomized rats. Eur J Clin Invest 2000;30(3):210-4.
5. Fisher P, Scott DL. A randomized controlled trial of homeopathy in rheumatoid arthritis. Rheumatology (Oxford) 2001;40(9):1052-5.
6. Fogelman I, Ribot C, Smith R, Ethgen D, Sod E, Reginster JY. Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2000;85(5):1895-900.
7. Guedes Junior FS. Osteoporose [Monografia de Especialização]. Vitória: Escola de Medicina da Santa Casa de Misericórdia de Vitória; 2003.
8. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of Risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999;282(14):1344-52.
9. Higdon J. Phosphorus. Oregon State University. Linus Pauling Institute. 2003. [cited 2004 Nov 17]. Available from: http://lpi.oregonstate.edu/ infocenter/minerals/phosphorus.
10. Jobst KA. Homeopathy, Hahnemann, and The Lancet 250 Years On: a case of the Emperor's New Clothes? J Altern Complement Med 2005; 11(5):751-4.
11. Jones JE, Kassity N. Varieties of alternative experience: complementary care in the neonatal intensive care unit. Clin Obstet Gynecol 2001;44(4):750-68.
12. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 2003;88(1):204-10.
13. National Osteoporosis Foundation [homepage on the Internet] [Cited 2004 Jun 20]. Available from: http://www.nof.org/osteoporosis.
14. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000;11(1):83-91.
15. a Mostra de pós-graduação da Universidade de Taubaté; 2004. Taubaté: Universidade de Taubaté; 2004. p. 306. outubro; Taubaté.
16. Tyler ML. Calcarea phosphorica. In: Tyler ML. Retratos de medicamentos homeopáticos. São Paulo: Santos; 1992. cap. 1. p. 181-7.
17. Ullman D. Homeopathic medicine: principles and research. In: Shoen AM, Wynn SG. Complementary and alternative veterinary medicine. Crawfordsville: R. R. Donnelley; 1998. p. 469-84.
18. a ed. São Paulo: Andrei; 1987.
19. Watts NB. Diagnosis and evaluation of patients with osteoporosis. South Med J 2004;97(6):540-1.